TrialThe New England journal of medicine2021
21-Gene Assay to Inform Chemotherapy Benefit in Node-Positive Breast Cancer.
Kevin Kalinsky et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
504 papers cite itlatest 60 shown
this paperpooled ittrialcites it